Aservo EquiHaler
ciclesonide
Table of contents
Overview
Aservo Equihaler is an anti-inflammatory medicine used to treat severe asthma in horses. Aservo Equihaler contains the active substance ciclesonide.
This EPAR was last updated on 28/02/2020
Authorisation details
Product details | |
---|---|
Name |
Aservo EquiHaler
|
Agency product number |
EMEA/V/C/004991
|
Active substance |
ciclesonide
|
International non-proprietary name (INN) or common name |
ciclesonide
|
Species |
Horses
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QR03BA08
|
Publication details | |
---|---|
Marketing-authorisation holder |
Boehringer Ingelheim Vetmedica GmbH
|
Date of issue of marketing authorisation valid throughout the European Union |
28/01/2020
|
Contact address |
Product information
Aservo EquiHaler - EMEA/V/C/004991 -
Contents
- Annex I - Summary of product characteristics
- Annex IIA - Manufacturing-authorisation holder responsible for batch release
- Annex IIB - Conditions of the marketing authorisation
- Annex IIIA - Labelling
- Annex IIIB - Package leaflet
Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.
Pharmacotherapeutic group
Pharmacotherapeutic group
-
Respiratory system
-
Other drugs for obstructive airway diseases, inhalants
Therapeutic indication
Therapeutic indication
For the alleviation of clinical signs of severe equine asthma (formerly known as Recurrent Airway Obstruction – (RAO), Summer Pasture Associated Recurrent Airway Obstruction – (SPA-RAO)).